{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:45:34Z","timestamp":1773297934847,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,9,22]],"date-time":"2009-09-22T00:00:00Z","timestamp":1253577600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s00404-009-1226-6","type":"journal-article","created":{"date-parts":[[2009,9,21]],"date-time":"2009-09-21T07:42:23Z","timestamp":1253518943000},"page":"1009-1014","source":"Crossref","is-referenced-by-count":28,"title":["High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome"],"prefix":"10.1007","volume":"281","author":[{"given":"Fatma Ferda","family":"Verit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,9,22]]},"reference":[{"key":"1226_CR1","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","volume":"352","author":"DA Ehrmann","year":"2005","unstructured":"Ehrmann DA (2005) Polycystic ovary syndrome. N Engl J Med 352:1223\u20131236","journal-title":"N Engl J Med"},{"key":"1226_CR2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/humrep\/dem356","volume":"23","author":"T Cascella","year":"2008","unstructured":"Cascella T, Palomba S, De Sio I, Manguso F, Giallauria F, De Simone B, Tafuri D, Lombardi G, Colao A, Orio F (2008) Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome. Hum Reprod 23:153\u2013159","journal-title":"Hum Reprod"},{"key":"1226_CR3","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1080\/08860220802406385","volume":"30","author":"S Bevc","year":"2008","unstructured":"Bevc S, Sabic S, Hojs R (2008) Atherosclerosis in hemodialysis patients: the role of microinflammation. Ren Fail 30:1012\u20131016","journal-title":"Ren Fail"},{"key":"1226_CR4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.atherosclerosis.2008.02.019","volume":"199","author":"I Ikonomidis","year":"2008","unstructured":"Ikonomidis I, Stamatelopoulos K, Lekakis J, Vamvakou GD, Kremastinos DT (2008) Inflammatory and non-invasive vascular markers: the multimarker approach for risk stratification in coronary artery disease. Atherosclerosis 199:3\u201311","journal-title":"Atherosclerosis"},{"key":"1226_CR5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.atherosclerosis.2008.08.039","volume":"202","author":"GK Hansson","year":"2009","unstructured":"Hansson GK (2009) Atherosclerosis, an immune disease: the Anitschkov lecture 2007. Atherosclerosis 202:2\u201310","journal-title":"Atherosclerosis"},{"key":"1226_CR6","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/jcem.86.6.7580","volume":"86","author":"CC Kelly","year":"2001","unstructured":"Kelly CC, Lyall H, Petrie JR, Gould GW, Connell JM, Sattar N (2001) Low-grade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab 86:2453\u20132455","journal-title":"J Clin Endocrinol Metab"},{"key":"1226_CR7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/09513590801893398","volume":"24","author":"R Thomann","year":"2008","unstructured":"Thomann R, Rossinelli N, Keller U, Tirri BF, De Geyter C, Ruiz J, Kr\u00e4nzlin M, Puder JJ (2008) Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome. Gynecol Endocrinol 24:199\u2013206","journal-title":"Gynecol Endocrinol"},{"key":"1226_CR8","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.2337\/diacare.23.12.1835","volume":"23","author":"M Fr\u00f6hlich","year":"2000","unstructured":"Fr\u00f6hlich M, Imhof A, Berg G, Hutchinson WL, Pepys MB, Boeing H, Muche R, Brenner H, Koenig W (2000) Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 23:1835\u20131839","journal-title":"Diabetes Care"},{"key":"1226_CR9","doi-asserted-by":"crossref","first-page":"6014","DOI":"10.1210\/jc.2005-1002","volume":"90","author":"JJ Puder","year":"2005","unstructured":"Puder JJ, Varga S, Kraenzlin M, De Geyter C, Keller U, M\u00fcller B (2005) Central fat excess in polycystic ovary syndrome: relation to low-grade inflammation and insulin resistance. J Clin Endocrinol Metab 90:6014\u20136021","journal-title":"J Clin Endocrinol Metab"},{"key":"1226_CR10","doi-asserted-by":"crossref","first-page":"987","DOI":"10.2459\/JCM.0b013e32830b58d4","volume":"9","author":"F Giallauria","year":"2008","unstructured":"Giallauria F, Orio F, Palomba S, Lombardi G, Colao A, Vigorito C (2008) Cardiovascular risk in women with polycystic ovary syndrome. J Cardiovasc Med (Hagerstown) 9:987\u2013992","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"1226_CR11","first-page":"19","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19\u201325","journal-title":"Fertil Steril"},{"key":"1226_CR12","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","volume":"21","author":"D Ferriman","year":"1961","unstructured":"Ferriman D, Gallwey JD (1961) Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 21:1440\u20131447","journal-title":"J Clin Endocrinol Metab"},{"key":"1226_CR13","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.fertnstert.2004.02.127","volume":"82","author":"JP Baillargeon","year":"2004","unstructured":"Baillargeon JP, Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Nestler JE (2004) Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity. Fertil Steril 82:893\u2013902","journal-title":"Fertil Steril"},{"key":"1226_CR14","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412\u2013419","journal-title":"Diabetologia"},{"key":"1226_CR15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.fertnstert.2003.05.027","volume":"81","author":"FV Comim","year":"2004","unstructured":"Comim FV, Spritzer PM (2004) Increased growth hormone response to clonidine in nonobese normoinsulinemic patients with polycystic ovary syndrome. Fertil Steril 81:108\u2013113","journal-title":"Fertil Steril"},{"key":"1226_CR16","unstructured":"World Health Organization (1994) WHO study group prevention of diabetes mellitus. Technical report series 844. World Health Organization, Geneva"},{"key":"1226_CR17","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.2337\/diacare.26.11.3160","volume":"26","author":"Expert Committee on the Diagnosis and Classification","year":"2003","unstructured":"Expert Committee on the Diagnosis and Classification (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26:3160\u20133167","journal-title":"Diabetes Care"},{"key":"1226_CR18","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0015-0282(03)00265-6","volume":"79","author":"B Yildirim","year":"2003","unstructured":"Yildirim B, Sabir N, Kaleli B (2003) Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome. Fertil Steril 79:1358\u20131364","journal-title":"Fertil Steril"},{"key":"1226_CR19","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"SM Grundy","year":"2005","unstructured":"Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F, American Heart Association, National Heart, Lung, Blood Institute (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute scientific statement. Circulation 112:2735\u20132752","journal-title":"Circulation"},{"issue":"4 Suppl","key":"1226_CR20","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.fertnstert.2008.09.070","volume":"91","author":"M Rizzo","year":"2009","unstructured":"Rizzo M, Berneis K, Spinas G, Rini GB, Carmina E (2009) Long-term consequences of polycystic ovary syndrome on cardiovascular risk. Fertil Steril 91(4 Suppl):1563\u20131567","journal-title":"Fertil Steril"},{"key":"1226_CR21","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.atherosclerosis.2008.11.028","volume":"205","author":"E Anuurad","year":"2009","unstructured":"Anuurad E, Tracy RP, Pearson TA, Kim K, Berglund L (2009) Synergistic role of inflammation and insulin resistance as coronary artery disease risk factors in African Americans and Caucasians. Atherosclerosis 205:290\u2013295","journal-title":"Atherosclerosis"},{"key":"1226_CR22","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00125-003-1090-z","volume":"46","author":"HF Escobar-Morreale","year":"2003","unstructured":"Escobar-Morreale HF, Villuendas G, Botella-Carretero JI, Sancho J, San Mill\u00e1n JL (2003) Obesity, and not insulin resistance, is the major determinant of serum inflammatory cardiovascular risk markers in pre-menopausal women. Diabetologia 46:625\u2013633","journal-title":"Diabetologia"},{"key":"1226_CR23","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0015-0282(99)00468-9","volume":"73","author":"KJ Mather","year":"2000","unstructured":"Mather KJ, Kwan F, Corenblum B (2000) Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity. Fertil Steril 73:150\u2013156","journal-title":"Fertil Steril"},{"key":"1226_CR24","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1210\/jc.2004-1045","volume":"90","author":"T Apridonidze","year":"2005","unstructured":"Apridonidze T, Essah PA, Iuorno MJ, Nestler JE (2005) Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 90:1929\u20131935","journal-title":"J Clin Endocrinol Metab"},{"key":"1226_CR25","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1530\/eje.0.1500525","volume":"150","author":"M M\u00f6hlig","year":"2004","unstructured":"M\u00f6hlig M, Spranger J, Osterhoff M, Ristow M, Pfeiffer AF, Schill T, Schl\u00f6sser HW, Brabant G, Sch\u00f6fl C (2004) The polycystic ovary syndrome per se is not associated with increased chronic inflammation. Eur J Endocrinol 150:525\u2013532","journal-title":"Eur J Endocrinol"},{"key":"1226_CR26","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.fertnstert.2007.11.031","volume":"91","author":"Y Wu","year":"2009","unstructured":"Wu Y, Zhang J, Wen Y, Wang H, Zhang M, Cianflone K (2009) Increased acylation-stimulating protein, C-reactive protein, and lipid levels in young women with polycystic ovary syndrome. Fertil Steril 91:213\u2013219","journal-title":"Fertil Steril"},{"key":"1226_CR27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1742-1241.2008.01897.x","volume":"63","author":"K Berneis","year":"2009","unstructured":"Berneis K, Rizzo M, Hersberger M, Rini GB, Di Fede G, Pepe I, Spinas GA, Carmina E (2009) Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome. Int J Clin Pract 63:56\u201362","journal-title":"Int J Clin Pract"},{"key":"1226_CR28","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/09513590701554306","volume":"23","author":"K Guzelmeric","year":"2007","unstructured":"Guzelmeric K, Alkan N, Pirimoglu M, Unal O, Turan C (2007) Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome. Gynecol Endocrinol 23:505\u2013510","journal-title":"Gynecol Endocrinol"},{"key":"1226_CR29","first-page":"97","volume":"11","author":"D K\u00f6nig","year":"2005","unstructured":"K\u00f6nig D, Deibert P, Winkler K, Berg A (2005) Association between LDL-cholesterol, statin therapy, physical activity and inflammatory markers in patients with stable coronary heart disease. Exerc Immunol Rev 11:97\u2013107","journal-title":"Exerc Immunol Rev"},{"key":"1226_CR30","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1210\/jc.2003-031096","volume":"89","author":"N Boulman","year":"2004","unstructured":"Boulman N, Levy Y, Leiba R, Shachar S, Linn R, Zinder O, Blumenfeld Z (2004) Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease. J Clin Endocrinol Metab 89:2160\u20132165","journal-title":"J Clin Endocrinol Metab"},{"key":"1226_CR31","doi-asserted-by":"crossref","unstructured":"Kaya C, Pabuccu R, Berker B, Satiroglu H (2009) Plasma interleukin-18 levels are increased in the polycystic ovary syndrome: relationship of carotid intima-media wall thickness and cardiovascular risk factors. Fertil Steril [Epub ahead of print]","DOI":"10.1016\/j.fertnstert.2008.07.204"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-009-1226-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-009-1226-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-009-1226-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T13:53:55Z","timestamp":1559051635000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-009-1226-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,22]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["1226"],"URL":"https:\/\/doi.org\/10.1007\/s00404-009-1226-6","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,22]]}}}